Skip to main content
Clinical Trials/NCT00299624
NCT00299624
Completed
N/A

Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging

Hopital Lariboisière2 sites in 1 country100 target enrollmentOctober 2005
ConditionsAging

Overview

Phase
N/A
Intervention
Not specified
Conditions
Aging
Sponsor
Hopital Lariboisière
Enrollment
100
Locations
2
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Detailed Description

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Registry
clinicaltrials.gov
Start Date
October 2005
End Date
August 2006
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hopital Lariboisière

Eligibility Criteria

Inclusion Criteria

  • age \<40 2 groups : 1 : no history of VTE 2 : history of VTE

Exclusion Criteria

  • antiaggregant or anticoagulant therapy at curative dose
  • arterial or thrombotic event in the last month

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials